ABcann Global Corporation (TSX-V:ABCN) announced today that, further to its news release of December 12, 2017, it has completed the acquisition of Harvest Medicine Inc.
Marijuana Investing
Hiku Brands to acquire leading Quebec based cannabis brand Maïtri
Hiku Brands Company Ltd. (CSE: HIKU), Canada's first vertically-integrated cannabis brand house, is pleased to announce it has entered into a binding letter of intent to acquire 100% of the issued and outstanding shares of Maïtri Group Inc., a Quebec-based cannabis accessory and design brand. The proposed acquisition represents the first brand acquisition by Hiku.
Harvest One Closes $40,250,000 Public Financing of Units, Including Exercise of Over-Allotment Option in Full
Harvest One Cannabis Inc. (TSXV:HVST) is pleased to announce that it has closed its previously announced "bought deal" offering of $40,250,000 of units of the Company, at a price of $1.82 per Unit
Organigram Announces Closing of $115 Million Convertible Debenture Bought Deal Financing
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has closed its previously announced short form prospectus offering of convertible unsecured debentures of the Company, on a bought deal basis, including the full exercise of the over-allotment option.
MedReleaf Corp. Announces Closing of Previously Announced Offering
MedReleaf Corp. (TSX:LEAF) is pleased to announce that it has closed its previously announced offering, on a "bought deal" basis, pursuant to a short form prospectus, of an aggregate of 5,000,000 units of the Company at a price of $26.50 per Unit for aggregate gross proceeds to the Company of $132,500,000.
Copy of Organigram Announces Closing of $115 Million Convertible Debenture Bought Deal Financing
Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has closed its previously announced short form prospectus offering of convertible unsecured debentures of the Company, on a bought deal basis, including the full exercise of the over-allotment option.
Hiku Brands, Canada's first retail & brand-focused licensed cannabis producer, begins trading on the CSE under the symbol "HIKU"
Hiku Brands Company Ltd. is pleased to announce that effective at the open of the market today, Hiku's common shares will be listed and will commence trading on the Canadian Securities Exchange under the four-letter stock symbol "HIKU".
Canopy Launches Canopy Ventures I, a $50 Million Venture Fund Targeting Growth Stage Companies Supporting the Legal Cannabis Industry
Canopy™, a venture capital firm and business accelerator for ancillary products and services companies in the legal cannabis industry, today announced the launch of Canopy Ventures I, a $50 million venture fund targeting growth stage companies.
MTech Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
MTech Acquisition Corp. (NASDAQ: MTECU) announced today that it priced its initial public offering of 5,000,000 units at $10.00 per unit. The units are expected to be listed on The NASDAQ Capital Market and trade under the ticker symbol “MTECU” beginning January 30, 2018.
CanniMed Therapeutics Inc. Reports Financial Results for 2017
CanniMed Therapeutics Inc. (TSX:CMED) today released its financial results for the fiscal year ended October 31, 2017, reporting ales of $16.7 million in 2017 were 70% higher than 2016.
ABcann Global Corporation Announces $70 Million Bought Deal Financing
ABcann Global Corporation (TSXV:ABCN) announced today that it has entered into an agreement with Canaccord Genuity Corp. and Eight Capital, on their own behalf and on behalf of a syndicate of underwriters, pursuant to which the Underwriters will purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of: (i) 11,500,000 units of the Company at a price of $3.50 per Unit for aggregate gross proceeds of $40,250,000; and (ii) 30,000 unsecured convertible debentures of the Company at a price of $1,000 per Convertible Debenture for aggregate gross proceeds of $30,000,000.
Emerald Health Therapeutics and DMG Blockchain Solutions Establish LOI to Create Cannabis Supply Chain Management System and E-Commerce Platform
Joint venture Cannachain Technologies would leverage blockchain technology designed to achieve unprecedented seed-to-sale provenance, safety and efficiency for the legal cannabis industry
Invictus MD Jumpstarts Revenue Stream With Sale of First 120 kg of Flower to Canopy Growth Corporation; Signs Definitive Agreement to Increase Ownership of AB Laboratories in Ontario from 33.3% to 50%
INVICTUS MD STRATEGIES CORP. (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce the sale of its first 120 kg of dried flower from AB Laboratories Inc., the licensed production facility under the Access to Cannabis for Medical Purposes Regulations, near Hamilton to Canopy Growth Corporation (TSX:WEED)
Canaccord Genuity Adds Dedicated Cannabis Investment Banking and Advisory Expertise in the U.S.
Canaccord Genuity is pleased to announce the expansion of its leading Cannabis investment banking practice with the addition of Shannon Soqui as Managing Director and Head of U.S. Cannabis Investment Banking.
3 Top Marijuana Penny Stocks to Buy Under $2
Money Morning looks at the 3 Top Marijuana Stocks to buy under $2, including InMed Pharma (CSE: IN | OTC IMLFF)